INTAGE HOLDINGS Inc. Logo

INTAGE HOLDINGS Inc.

Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.

4326 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区神田練塀町3番地インテージ秋葉原ビル
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

INTAGE HOLDINGS Inc., established in 1960, is a leading marketing research and business intelligence group. The company operates through three core segments to provide data-driven insights and solutions. The Marketing Support (Consumer Goods & Services) division offers comprehensive support to clients, including consumer goods manufacturers, by leveraging panel research, custom research, and advanced data analysis. The Marketing Support (Healthcare) division assists pharmaceutical companies with research, development, and marketing activities through prescription data analysis and specialized market research. The Business Intelligence segment provides technology services encompassing software development, system operation, data center management, and AI-driven consulting to support enterprise management strategies and improve business processes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 08:30
Regulatory News Service
確認書
Japanese 8.9 KB
2025-09-24 08:30
Annual Report
有価証券報告書-第53期(2024/07/01-2025/06/30)
Japanese 1.6 MB
2025-02-06 07:30
Interim Report
半期報告書-第53期(2024/07/01-2025/06/30)
Japanese 268.3 KB
2025-02-06 07:30
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-10-01 08:05
Post-Annual General Meeting Information
臨時報告書
Japanese 28.5 KB
2024-09-26 09:48
Regulatory News Service
確認書
Japanese 8.9 KB
2024-09-26 09:48
Regulatory News Service
内部統制報告書-第52期(2023/07/01-2024/06/30)
Japanese 23.9 KB
2024-09-26 09:47
Annual Report
有価証券報告書-第52期(2023/07/01-2024/06/30)
Japanese 1.7 MB
2024-08-07 08:32
Board/Management Information
臨時報告書
Japanese 19.2 KB
2024-08-07 08:31
Audit Report / Information
臨時報告書
Japanese 20.6 KB
2024-06-17 08:33
Regulatory News Service
臨時報告書
Japanese 19.5 KB
2024-05-09 08:33
Regulatory News Service
確認書
Japanese 9.0 KB
2024-05-09 08:33
Quarterly Report
四半期報告書-第52期第3四半期(2024/01/01-2024/03/31)
Japanese 218.2 KB
2024-04-22 08:31
M&A Activity
臨時報告書
Japanese 23.0 KB
2024-02-07 07:31
Report Publication Announcement
確認書
Japanese 9.1 KB

Automate Your Workflow. Get a real-time feed of all INTAGE HOLDINGS Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for INTAGE HOLDINGS Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.